Organic Light Emitting Diode (OLED) technology, originally developed for consumer electronics, is now emerging as a transformative tool in biomedicine. This blog explores the diverse biomedical applications of OLEDs, highlighting their advantages such as flexibility, biocompatibility, and efficient light emission. OLEDs are increasingly used in wearable diagnostics, phototherapy, implantable medical devices, and real-time health monitoring […]
Author Archives: truemeds
Metal–organic frameworks (MOFs) are a class of porous crystalline materials constructed from metal ions and organic linkers. This blog explores their fundamental structure and highlights their broad applications across five key domains: gas storage and separation, catalysis and energy systems, biomedical technologies, and environmental remediation. The article also examines current challenges in MOF research—such as […]
Histamine in the Brain: Despite major advances in antidepressant pharmacotherapy, a significant proportion of patients with major depressive disorder (MDD) fail to respond to conventional treatments targeting serotonin, dopamine, and norepinephrine. Emerging research highlights histamine—a monoamine traditionally associated with allergy and immune function—as a powerful neuromodulator within the central nervous system. This blog explores the […]
Rewiring Fat: How β-Adrenergic Receptors Are Unlocking New Paths in Obesity and Metabolic Therapy. Recent discoveries in adipose tissue biology have redefined fat from a passive energy reservoir to a dynamic endocrine organ with immense therapeutic potential. Central to this transformation is the evolving understanding of β-adrenergic receptors (βARs), particularly their role in activating lipolysis, […]
09
Jun
Jun
Elinzanetant is a first-in-class, non-hormonal dual neurokinin (NK-1/NK-3) receptor antagonist developed to treat vasomotor symptoms (VMS) like hot flashes in menopausal women. It targets overactive KNDy neurons in the hypothalamus, restoring temperature regulation disrupted by declining estrogen. Clinical trials (OASIS-1, -2, -3) demonstrated significant, sustained reduction in VMS severity and frequency with a favorable safety […]
09
Jun
Jun
Peficitinib Hydrobromide is a Janus kinase (JAK) inhibitor developed to treat moderate-to-severe rheumatoid arthritis, particularly in patients unresponsive to conventional DMARDs. It targets JAK1, JAK2, JAK3, and TYK2, reducing inflammation through immune pathway modulation. Clinical trials have shown that peficitinib provides effective symptom control and disease remission, with a manageable safety profile over long-term use. […]
Pulmonary nodules are small, round growths found in the lungs, often discovered incidentally during chest imaging. While most are benign, some can indicate early-stage lung cancer. This article provides an overview of pulmonary nodules, including their causes, diagnostic techniques such as CT and PET scans, risk factors for malignancy, and management strategies. It also outlines […]
Multiple myeloma (MM) remains an incurable plasma cell malignancy, driven not only by genetic alterations but also by complex interactions within the tumor microenvironment. Recent research highlights the critical role of chemokines—small signaling proteins—in promoting MM progression, metastasis, bone destruction, and immune evasion. Some chemokines act as pro-tumor agents, aiding drug resistance and dissemination, while […]
Lipoprotein lipase (LPL) is increasingly recognized as a pivotal enzyme in the pathophysiology of cardiovascular disease, particularly in individuals with obesity and type 2 diabetes. Traditionally viewed as a facilitator of fatty acid delivery for energy metabolism, LPL also plays a significant role in atherogenesis when misregulated in immune cells. This blog explores LPL’s dual […]
Spliceostatin A is a potent natural compound known for its ability to inhibit pre-mRNA splicing by targeting the SF3b complex within the spliceosome. This blog explores its mechanism of action, therapeutic potential in cancer and neurodegenerative diseases, and its growing role as a molecular tool in RNA biology research. While its clinical application faces challenges […]